Tag: Alzheimer’s disease
Multi-arm platform trials could revolutionize neurological disease research
Platform trials could test 15-20 neurological treatments per decade compared to 3-5 using traditional methods. New Lancet commentary argues this…
Regulatory Agencies Split on New Alzheimer’s Drugs as Hope Meets Uncertainty
Regulatory agencies worldwide are delivering conflicting assessments of novel Alzheimer's treatments, creating uncertainty for millions of patients. The Lancet examines…
CBD Shows Promise in Reducing Alzheimer’s-Related Brain Inflammation
New preclinical research suggests CBD may help fight Alzheimer's disease by reducing neuroinflammation in mouse models. The study found that…
Why Alzheimer’s disease hits women harder: new evidence on sex-specific risk factors
A UC San Diego study of over 17,000 adults reveals that women are disproportionately sensitive to dementia risk factors including…
Submit Your Paper to GMJ
No APC until January 2027.